Lexaria Bioscience Corp —— 资产负债表 (NASDAQ:LEXX) | MetaTrader

展开完整图表

Financials

概览声明统计

每季度年度

总资产 2.83 M13.27 M7.83 M3.08 M8.87 M4.18 M 负债总额 345.98 K203.26 K201.44 K403.91 K1.21 M1.57 M 权益总额 2.48 M12.86 M7.63 M2.68 M7.66 M2.6 M 负债及股东权益总额 2.83 M13.27 M7.83 M3.08 M8.87 M4.18 M 总债务 156.1 K39.4 K0——— 净债务 -1.16 M-11.71 M-6.16 M———

新闻

Lexaria启动2026年药物递送技术研究计划

Lexaria launches 2026 research program for drug delivery tech

Lexaria Bioscience股东在年度会议上批准董事会选举和审计师任命

Lexaria Bioscience shareholders approve board elections and auditor at annual meeting

Lexaria的DehydraTECH技术显示GLP-1药物副作用减少

Lexaria’s DehydraTECH shows reduced side effects in GLP-1 drugs

Why Bark Shares Are Trading Higher By 20%; Here Are 20 Stocks Moving Premarket - Abivax (NASDAQ:ABVX), Rich Sparkle Holdings (NASDAQ:ANPA)

Capital One Financial To Rally More Than 24%? Here Are Top Analyst Forecasts For Friday - Agios Pharmaceuticals (NASDAQ:AGIO), Capital One Finl (NYSE:COF)

H.C. Wainwright将Lexaria Bioscience股票目标价从4美元下调至1.50美元

Lexaria Bioscience stock price target cut to $1.50 from $4 at H.C. Wainwright

DehydraTECH-司美格鲁肽显示比Rybelsus副作用减少48%

DehydraTECH-semaglutide shows 48% fewer side effects than Rybelsus